Safety and Efficacy of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (VENUS)
Clinical trial NCT06196840 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06196840
- Sponsor
- Innostellar Biotherapeutics Co.,Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-24
- Primary completion
- 2025-06-24
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.